GSK-3β inhibitor 3
CAS No. 1448990-73-5
GSK-3β inhibitor 3 ( —— )
产品货号. M34769 CAS No. 1448990-73-5
GSK-3β inhibitor 3 是一种有效,选择性,不可逆和共价的糖原合酶激酶 3β (GSK-3β) 抑制剂,IC50 值为 6.6 μM。GSK-3β inhibitor 3 可用于急性早幼粒细胞白血病的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1881 | 有现货 |
|
| 10MG | ¥2822 | 有现货 |
|
| 25MG | ¥4566 | 有现货 |
|
| 50MG | ¥6436 | 有现货 |
|
| 100MG | ¥8397 | 有现货 |
|
| 200MG | ¥11250 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥2166 | 有现货 |
|
生物学信息
-
产品名称GSK-3β inhibitor 3
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK-3β inhibitor 3 是一种有效,选择性,不可逆和共价的糖原合酶激酶 3β (GSK-3β) 抑制剂,IC50 值为 6.6 μM。GSK-3β inhibitor 3 可用于急性早幼粒细胞白血病的研究。
-
产品描述GSK-3β inhibitor 3 is a potent, selective, irreversible and covalent inhibitor of Glycogen Synthase Kinase 3β (GSK-3β), with an IC50 of 6.6 μM. GSK-3β inhibitor 3 can be used for the research of acute promyelocytic leukemia.
-
体外实验GSK-3β inhibitor 3 (compound 4-3) (100 μM) inhibits GSK-3α activity by 87.3%.GSK-3β inhibitor 3 (6.25-100 μM; 24-48 h) dose-dependently inhibits the growth of NB4 and NB4-R1 cells.GSK-3β inhibitor 3 (12.5-100 μM; 24 h) significantly increases the percentage of apoptosis in a dose-dependent pattern in NB4 and NB4-R1 cells.Cell Viability Assay Cell Line:NB4 and NB4-R1 cells Concentration:6.25, 12.5, 25, 50, 100 μM Incubation Time:24, 48 hours Result:Inhibited the cell viability, with IC50s of 19.56 μM and 26.42 μM in NB4 and NB4-R1 cells at 24 h, respectively.Had little cytotoxicity on human normal liver cells (LO2) and human umbilical vein endothelial cells (HUVECs).Apoptosis Analysis Cell Line:NB4 and NB4-R1 cells Concentration:12.5, 25, 50, 100 μM Incubation Time:24 hours Result:Induced cell apoptosis.
-
体内实验GSK-3β inhibitor 3 (compound 4-3) (15 mg/kg/d; i.p. for 2 weeks) inhibits tumor growth of mice by 75.97% relative to vehicle control.GSK-3β inhibitor 3 (15 mg/kg; a single i.p.) shows long T1/2 of 14.2 h, high AUC values (AUClast=3503.42 ng/mL?h), and maximum concentration (Cmax=515 ng/mL) in mice.Animal Model:Balb/c female nude mice were injected leukemia cellsDosage:15 mg/kg/d Administration:I.p. for 2 weeks Result: Inhibited localized growth in NB4 cells.Had mild weight loss compared with control.Animal Model:Male ICR mice (30 g) Dosage:15 mg/kg (Pharmacokinetic Analysis) Administration:A single i.p.Result:T1/2=14.2 h; AUClast=3503.42 ng/mL?h; Cmax=515 ng/mL.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis | GSK-3
-
研究领域——
-
适应症——
化学信息
-
CAS Number1448990-73-5
-
分子量327.37
-
分子式C18H14FNO2S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 250 mg/mL (763.66 mM; 超声助溶 )
-
SMILESFc1ccc(cc1)C1CC(=O)N(C(=O)C=C)c2ccccc2S1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Zhang P, et, al. Discovery of Novel Benzothiazepinones as Irreversible Covalent Glycogen Synthase Kinase 3β Inhibitors for the Treatment of Acute Promyelocytic Leukemia. J Med Chem. 2021 May 24.?
产品手册
关联产品
-
LDCA
LDCA 是一种双重打击代谢调节剂,可抑制 LDH-A 酶活性,刺激恶性群体的凋亡。LDCA 可用于致癌进展的研究。
-
SKI-178
SKI-178 是一种鞘氨醇激酶 1 (SphK1) 抑制剂,IC50 为 0.1-1.8 μM。
-
Forodesine
Forodesine (BCX-1777) 是一种高效的口服活性的嘌呤核苷磷酸化酶 (PNP) 抑制剂,对人,小鼠,大鼠,猴和狗 PNP 的 IC50 值在 0.48 至 1.57 nM 之间。Forodesine 是有效的人类淋巴细胞增殖抑制剂,可通过增加 dGTP 水平而诱导白血病细胞凋亡 (apoptosis)。
021-51111890
购物车()
sales@molnova.cn

